GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Price-to-Tangible-Book

Inoviq (ASX:IIQ) Price-to-Tangible-Book : 4.74 (As of Oct. 31, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq Price-to-Tangible-Book?

As of today (2024-10-31), Inoviq's share price is A$0.46. Inoviq's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was A$0.10. Hence, Inoviq's Price to Tangible Book Ratio of today is 4.74.

The historical rank and industry rank for Inoviq's Price-to-Tangible-Book or its related term are showing as below:

ASX:IIQ' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.1   Med: 0.71   Max: 52.22
Current: 4.6

During the past 13 years, Inoviq's highest Price to Tangible Book Ratio was 52.22. The lowest was 0.10. And the median was 0.71.

ASX:IIQ's Price-to-Tangible-Book is ranked worse than
68.07% of 166 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.765 vs ASX:IIQ: 4.60

A closely related ratio is called PB Ratio. As of today, Inoviq's share price is A$0.46. Inoviq's Book Value per Sharefor the quarter that ended in Jun. 2024 was A$0.19. Hence, Inoviq's P/B Ratio of today is 2.43.


Inoviq Price-to-Tangible-Book Historical Data

The historical data trend for Inoviq's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Price-to-Tangible-Book Chart

Inoviq Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 52.22 2.15 8.76 5.77

Inoviq Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 5.33 8.76 9.37 5.77

Competitive Comparison of Inoviq's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Inoviq's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inoviq's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Inoviq's Price-to-Tangible-Book falls into.



Inoviq Price-to-Tangible-Book Calculation

Inoviq's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=0.46/0.097
=4.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Inoviq Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Inoviq's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Inoviq Business Description

Traded in Other Exchanges
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq Headlines

No Headlines